[1]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-EP2796461,2014,A1Locationinpatent:Paragraph0057-0059;0097-0103
[2]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-US2014/343283,2014,A1Locationinpatent:Paragraph0130-0136
[3]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-TWI612039,2018,BLocationinpatent:Paragraph0078;00119;00121;00123;00124;00125
[1]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-WO2014/198210,2014,A1Locationinpatent:Page/Pagecolumn10;11
[2]CurrentPatentAssignee:BETTAPHARMACEUTICALSCOLTD-WO2014/198212,2014,A1Locationinpatent:Page/Pagecolumn11;12;13
Title: Tan F, et al. Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies. Lung Cancer. 2012 May;76(2):177-82.